An a evaluation suggested there was no overall net clinical a benefit in patients receiving the a drug in the a study , the companies said in a a statement distributed by Business Wire .
An a evaluation of 240 a arthritis patients suggested there was no overall net clinical a benefit from taking the a medicine , the companies said in a a statement distributed by Business Wire .